Enough Will They-Won’t They! FDA Pushes for Permanent Rare Pediatric Disease PRVs April 17, 2026 By Charles D. Snow & James E. Valentine —

https://www.thefdalawblog.com/2026/04/enough-will-they-wont-they-fda-pushes-for-permanent-rare-pediatric-disease-prvs/?utm_source=rss&utm_medium=rss&utm_campaign=enough-will-they-wont-they-fda-pushes-for-permanent-rare-pediatric-disease-prvs As any well-rounded consumer of television knows, one of the most ubiquitous tropes in sitcoms is the “will they-won’t they” dynamic. Take your pick: Ross and Rachel from Friends, Jim and Pam from The Office, or Mulder and Scully from The X-Files. It’s riveting and exhausting. FDA has grown similarly tired of Congress’s will they-won’t they decision-making when it comes to the reauthorization of the Rare Pediatric Disease (RPD) Priority Review Voucher (PRV) program.